- Who We Are
- Who We Serve
- Our Tissues & Products
- Contact Us
This advanced graft is versatile and conformable, to fill spaces without the need for surgeons to use templates or anchors.
This advanced cartilage treatment is readily available which allows patients to get the treatment they need in a timely manner without having to go on a waiting list. It also eliminates two-stage procedures which
CartiMax offers surgeons these advantages:
Viable Chondrocytes — Provides functioning, viable chondrocytes and an extracellular matrix that contains the necessary building blocks for cartilage repair such as type II collagen, proteoglycans, and endogenous growth factors.
Extended Shelf Life — Demonstrates stable viability up to one-year post-cryopreservation.
High Volume of Material — Provides enough materials to fill a 5cm2 lesion, while other products may require multiple packages to treat the same volume.
Fewer Steps — Requires fewer steps and saves valuable time over comparable products, which may require measuring, using a foil template, shaping, trimming, and suturing.
MTF Biologics is the largest tissue bank in the world and a nonprofit, physician-led organization that, for more than 30 years, has honored the donated gift by developing innovative, effective allograft solutions that help people heal and save lives. MTF Biologics developed CartiMax® in partnership with ConMed, a global medical technology company that specializes in improving patient outcomes through the development and sale of surgical and patient monitoring products and services.